Monoclonal Antibodies for Prevention and Treatment of COVID-19

JAMA. 2020 Jul 14;324(2):131-132. doi: 10.1001/jama.2020.10245.

Authors

Mary Marovich¹, John R Mascola¹, Myron S Cohen²

Affiliations

¹ Vaccine Research Program, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
² Institute for Global Health and Infectious Diseases, University of North Carolina, Chapel Hill.

PMID: 32539093
DOI: 10.1001/jama.2020.10245

No abstract available

MeSH terms

Antibodies, Monoclonal / therapeutic use*
Antibodies, Neutralizing / therapeutic use
Antibodies, Viral / therapeutic use
Betacoronavirus
COVID-19
Coronavirus Infections / prevention & control*
Coronavirus Infections / therapy*
Humans
Pandemics / prevention & control*
Pneumonia, Viral / prevention & control*
Pneumonia, Viral / therapy*
SARS-CoV-2
Spike Glycoprotein, Coronavirus / immunology

Substances

Antibodies, Monoclonal
Antibodies, Neutralizing
Antibodies, Viral
Spike Glycoprotein, Coronavirus
spike protein, SARS-CoV-2